ArticleJournal of oral biology and craniofacial research
SHED secretome hydrogel combined with α-mangostin for periodontal bone regeneration: In vivo study.
Article in Journal of oral biology and craniofacial research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Periodontitis is a long-term inflammatory condition that results in the gradual loss of bone tissue surrounding the teeth. Cells derived from the pulp of human exfoliated deciduous teeth, also known as SHED cells, are very valuable in regenerative medicine due to their ease of access, rapid multiplication, and the ability to develop into multiple cell types. Additionally, medicinal plants such as mangosteen, which are rich in α-mangostin, show promise for periodontitis treatment. This compound, possessing potent anti-inflammatory and antioxidant properties. The purpose of this study was to investigate the molecular mechanisms of SHED secretome-loaded hydrogel combined with α-mangostin on the periodontal bone regeneration processes in a rat model. Material and method: Sixty Male Wistar rats (n = 12 per group) were divided into five group: Control positive, Control negative, Treatment I, Treatment II, and Treatment III. After treatment, rats were humanely euthanized at three distinct time points (7, 14, and 21 days). Mandibular sections were then collected and analyzed using immunohistochemistry to quantify the expression levels of TNF-α, IL-10, and BMP-2. One-way ANOVA and a post hoc test (P < 0.05) were used to assess the data. Result: The result showed decrease in TNF-α expression, and a significant increase in the expression of IL-10 and BMP-2 at 7th, 14th, and 21 days. Conclusion: The combination of hydrogel SHED secretome α-mangostin effectively modulates the inflammatory environment by reducing TNF-α level and enhancing IL-10 production, thereby promoting the expression of the osteogenic factor BMP-2. This finding suggests an effective strategy for periodontal bone regeneration processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.